PSO EASY

ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช (PsA) โ€“ ื›ืœ ืžื” ืฉืฆืจื™ืš ืœื“ืขืช

ืžืชื•ืš ืžืืžืจ ืฉื›ืชื‘ื” ื“”ืจ ื•ื™ืงื˜ื•ืจื™ื” ืคื•ืจืจ – ืจื•ืคืื” ื‘ื›ื™ืจื” ื‘ืžื›ื•ืŸ ื”ืจื™ืื•ืžื˜ื•ืœื•ื’ื™ ื‘ืžืจื›ื– ื”ืจืคื•ืื™ ืชืœ-ืื‘ื™ื‘ ืข”ืฉ ืกื•ืจืืกืงื™ (ืื™ื›ื™ืœื•ื‘)

ืžื”ื™ ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช (PsA)?

ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืžื”ื•ื•ื” ืกื•ื’ ืฉืœ ื“ืœืงืช ืžืคืจืงื™ื ื›ืจื•ื ื™ืช ืฉืžืชืคืชื—ืช ืขืœ ืจืงืข ืฉืœ ื”ืžื—ืœื” ื”ืขื•ืจื™ืช ื”ื›ืจื•ื ื™ืช ืคืกื•ืจื™ืื–ื™ืก. ืœืžื—ืœื” ืžื’ื•ื•ืŸ ืชืกืžื™ื ื™ื ื•ื‘ื™ื˜ื•ื™ื™ื ืงืœื™ื ื™ื™ื, ื›ื•ืœืœ ื“ืœืงืช ื‘ืžืคืจืงื™ื ื•ื“ืœืงืช ื‘ืžื‘ื ื™ื ื”ืกืžื•ื›ื™ื ืœืžืคืจืงื™ื ื›ื’ื•ืŸ ืื–ื•ืจื™ ื”ื—ื™ื‘ื•ืจ ื‘ื™ืŸ ื’ื™ื“ื™ื ืœืขืฆื. ื‘ื“ื•ืžื” ืœืคืกื•ืจื™ืื–ื™ืก, ื’ื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืžืื•ืคื™ื™ื ืช ื‘ืชืงื•ืคื•ืช ืฉืœ ื›ืื‘ื™ื ื—ื–ืงื™ื ื•ื”ืคื•ื’ื” ืžื›ืื‘ื™ื.

ืืฆืœ ืจื•ื‘ ื”ืžื˜ื•ืคืœื™ื ืฉืžืื•ื‘ื—ื ื™ื ื‘ืžื—ืœื”, ืคืกื•ืจื™ืื–ื™ืก ืžืงื“ื™ื ืืช ื”ื”ื•ืคืขื” ืฉืœ ื“ืœืงืช ื”ืžืคืจืงื™ื ืœืคื—ื•ืช ื‘ืžืกืคืจ ืฉื ื™ื – ื‘ืžืžื•ืฆืข ื›ืขืฉืจ ืฉื ื™ื. ืขื ื–ืืช, ื‘ื—ืœืง ืžื”ืžืงืจื™ื ืžื—ืœืช ืžืคืจืงื™ื ืžื•ืคื™ืขื” ื™ื—ื“ ืขื ื”ื•ืคืขืช ื”ื ื’ืขื™ื ื”ืขื•ืจื™ื™ื, ื•ื‘ืžื™ืขื•ื˜ ื”ืžืงืจื™ื – ืกื‘ื™ื‘ 10% ืžื”ืžืื•ื‘ื—ื ื™ื – ื“ืœืงืช ื”ืžืคืจืงื™ื ืืฃ ืžืงื“ื™ืžื” ืืช ื”ืคืกื•ืจื™ืื–ื™ืก, ื“ื‘ืจ ืฉืขืฉื•ื™ ืœื”ืงืฉื•ืช ืขืœ ื”ืื‘ื—ื•ืŸ ื‘ืฉืœื‘ื™ื ื”ืจืืฉื•ื ื™ื™ื. ื”ืžื—ืœื” ื ื•ื˜ื” ืœื”ื•ืคื™ืข ื‘ื’ื™ืœ 30-50, ืืš ื™ื›ื•ืœื” ืœื”ื•ืคื™ืข ื‘ื›ืœ ื’ื™ืœ. ืฉื›ื™ื—ื•ืชื” ื“ื•ืžื” ื‘ื’ื‘ืจื™ื ื•ื‘ื ืฉื™ื.

ืฉื›ื™ื—ื•ืชื” ื ืขื” ื‘ื™ืŸ 1% ืœ-3% ื‘ืงืจื‘ ื”ืื•ื›ืœื•ืกื™ื™ื” ื›ื•ืœื”. 7-42% ืžื”ืกื•ื‘ืœื™ื ืžืคืกื•ืจื™ืื–ื™ืก ื™ืคืชื—ื• ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช (ืืจื˜ืจื™ื˜ื™ืก ืคืกื•ืจื™ืื˜ื™ืช) โ€“ ืžื—ืœื” ื›ืจื•ื ื™ืช ื‘ื” ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ ืฉืœ ื”ื’ื•ืฃ ืชื•ืงืคืช ืืช ื”ืžืคืจืงื™ื ื‘ืชื”ืœื™ืš ื“ืœืงืชื™.

ื“ืœืงืช ื”ืžืคืจืงื™ื ื”ืคืกื•ืจื™ืื˜ื™ืช ื™ื›ื•ืœื” ืœืขืจื‘ ืžื’ื•ื•ืŸ ืžืคืจืงื™ื ื‘ื“ื’ืžื™ ืžืขื•ืจื‘ื•ืช ืฉื•ื ื™ื: ื“ืœืงืช ื‘ืžืคืจืง ื‘ื•ื“ื“, ื“ืœืงืช ืืกื™ืžื˜ืจื™ืช ื‘ืžืคืจืงื™ื ืกืคื•ืจื™ื ื’ื“ื•ืœื™ื ื‘ื’ืคื™ื™ื ืชื—ืชื•ื ื•ืช, ื“ืœืงืช ื‘ืžืคืจืงื™ื ืงื˜ื ื™ื ื‘ื›ืคื•ืช ื”ื™ื“ื™ื™ื ื‘ื“ื’ืžื™ื ืฉื•ื ื™ื ื›ื•ืœืœ ืขื™ืจื•ื‘ ื”ืžืคืจืงื™ื ื”ืงื˜ื ื™ื ื”ื“ื™ืกื˜ืœื™ื™ื ื‘ืืฆื‘ืขื•ืช ื›ืฃ ื”ื™ื“ (DIP) ื•ืžืขื•ืจื‘ื•ืช ื’ื‘ ื‘ื“ื•ืžื” ืœื“ืœืงืช ื—ื•ืœื™ื•ืช ืžืงืฉื—ืช. ืชืกืžื™ื ื™ื ื ื•ืกืคื™ื ืฉื™ื›ื•ืœื™ื ืœื”ื•ืคื™ืข ื‘ืกื•ื‘ืœื™ื ืžื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื”ื ื‘ื™ืŸ ื”ื™ืชืจ ืืฆื‘ืขื•ืช ื ืงื ื™ืงื™ื™ื” (ื“ืงื˜ื™ืœื™ื˜ื™ืก) ื•ื ื–ืง ืื•ืคื™ื™ื ื™ ื‘ืฆื™ืคื•ืจื ื™ื™ื.

ืฉื›ื™ื—ื•ืช ื”ืžื—ืœื” ื‘ื™ืฉืจืืœ

ื‘ื™ืฉืจืืœ, ืžื—ืงืจ ืฉืžืชื‘ืกืก ืขืœ ื ืชื•ื ื™ ื›ืœืœ ื”ืžื‘ื•ื˜ื—ื™ื ื‘ืงื•ืคืช ื—ื•ืœื™ื ื›ืœืœื™ืช ืืฉืจ ืžืžืฆืื™ื• ื“ื•ื•ื—ื• ื‘ื™ื ื•ืืจ 2018 ื‘ื›ืชื‘ ื”ืขืช Arthritis Research and Therapy, ื”ืขืœื” ื›ื™ ืฉื›ื™ื—ื•ืช ื”ืžื—ืœื” ื ืžื•ื›ื” ื™ื—ืกื™ืช: 11 ื—ื•ืœื™ื ืœื›ืœ ืžืื” ืืœืฃ ืชื•ืฉื‘ื™ื. ืขื•ื“ ื ืžืฆื ื‘ืžื—ืงืจ ื›ื™ ื‘ื™ืŸ ื”ืฉื ื™ื 2006 ืœ-2015 ืฉื™ืขื•ืจื™ ื”ืชื—ืœื•ืื” ื‘ืžื—ืœื” ื‘ื™ืฉืจืืœ ื›ืžืขื˜ ื•ื”ื•ื›ืคืœื•, ื‘ืขื•ื“ ืฉื‘ืขื•ืœื ื›ื•ืœื• ืžื“ื•ื•ื— ืขืœ ื™ืฆื™ื‘ื•ืช ื‘ืชื—ืœื•ืื”. ืชื—ืœื•ืื” ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื‘ื™ืฉืจืืœ ื–ื•ื”ืชื” ื‘ืขื‘ื•ื“ื” ื‘ืขื™ืงืจ ื‘ืงืจื‘ ื™ื”ื•ื“ื™ื, ืื ืฉื™ื ืžืžืขืžื“ ืกื•ืฆื™ื•ืืงื•ื ื•ืžื™ ื’ื‘ื•ื” ื•ืื ืฉื™ื ืขื ืขื•ื“ืฃ ืžืฉืงืœ ื•ื”ืฉืžื ื”.

ืžื”ื ื”ืชืกืžื™ื ื™ื ื”ืื•ืคื™ื™ื ื™ื™ื ืœืžื—ืœื”?

ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืœื•ืœื” ืœื”ืฉืคื™ืข ืขืœ ืžืคืจืงื™ื ืจืง ื‘ืฆื“ ืื—ื“ ืฉืœ ื”ื’ื•ืฃ ืื• ื‘ืฉื ื™ ื”ืฆื™ื“ื™ ื”ื’ื•ืฃ.

ื”ืชืกืžื™ื ื™ื ื‘ืžืคืจืงื™ื ืฉืžื•ืฉืคืขื™ื ืžื”ืžื—ืœื” ื“ื•ืžื™ื ืœืืœื• ืฉื ืฆืคื™ื ืืฆืœ ื—ื•ืœื™ื ื‘ื“ืœืงืช ืžืคืจืงื™ื ืฉื’ืจื•ื ืชื™ืช (ืจืื•ืžื˜ื™ื–ื), ืœืจื‘ื•ืช:

  • ื›ืื‘ื™ื ื‘ืžืคืจืงื™ื
  • ื ื•ืงืฉื•ืช ื‘ืžืคืจืงื™ื, ื•ื‘ื›ืœืœ ื–ื” ื’ื ืชื•ืคืขื” ืฉืœ ื ื•ืงืฉื•ืช ื‘ื•ืงืจ ื”ืžืงืฉื” ืขืœ ื”ืงื™ืžื” ืžื”ืžื™ื˜ื”, ืืฉืจ ืžื•ืงืœืช ื‘ื”ืžืฉืš ื”ื™ื•ื
  • ื ืคื™ื—ื•ืช ื‘ืžืคืจืงื™ื
  • ื—ื•ื ื•ืจื’ื™ืฉื•ืช ืœืžื’ืข ื‘ืžืคืจืงื™ื
  • ื‘ืฉื•ื ื” ืžื“ืœืงืช ืžืคืจืงื™ื ืฉื’ืจื•ื ืชื™ืช, ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืœืขื™ืชื™ื ืืกื™ืžื˜ืจื™ืช ื•ื ื•ื˜ื” ืœืขืจื‘ ืžืคืจืงื™ื ืžืจื•ื—ืงื™ื ืฉืœ ื”ืืฆื‘ืขื•ืช ื‘ื›ืคื•ืช ื”ื™ื“ื™ื™ื.

ืžืขื‘ืจ ืœื›ืš, ืชืกืžื™ื ื™ื ื—ื•ืฅ ืžืคืจืงื™ื™ื ืื•ืคื™ื™ื ื™ื™ื ืœื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืฉื•ื™ื™ื ืœื›ืœื•ืœ:

  • ืืฆื‘ืข ื ืงื ื™ืงื™ื™ื”: ืืฆื‘ืขื•ืช ื‘ื›ืคื•ืช ื”ื™ื“ื™ื™ื ื•/ืื• ื”ืจื’ืœื™ื™ื ืฉื”ืชืคืชื—ื” ื‘ื”ืŸ ื“ืœืงืช ื”ืงืจื•ื™ื” ‘ื“ืงื˜ื™ืœื™ื˜ื™ืก’ ื”ื’ื•ืจืžืช ืœืืฆื‘ืขื•ืช ืœื”ืจืื•ืช ื›ื ืงื ื™ืงื™ื•ืช ืชืคื•ื—ื•ืช, ืžืจืื” ืฉื”ื•ื‘ื™ืœ ืœื›ื™ื ื•ื™ โ€“ ‘ืืฆื‘ืขื•ืช ื ืงื ื™ืงื™ื”’. ื”ืชื•ืคืขื” ืžืœื•ื•ื” ื‘ื›ืื‘ ืžืฉืžืขื•ืชื™ ื‘ืฉืœื‘ ื”ื—ืจื™ืฃ ืฉืœ ื”ื“ืœืงืช.
  • ื›ืื‘ื™ื ื‘ื›ืคื•ืช ื”ืจื’ืœื™ื™ื: ื›ืื‘ื™ื ื‘ื›ืคื•ืช ื”ืจื’ืœื™ื™ื ื‘ืื–ื•ืจื™ื ืฉื‘ื”ื ื’ื™ื“ื™ื ื•ืจืฆื•ืขื•ืช ืžืชื—ื‘ืจื™ื ืœืขืฆืžื•ืช, ื•ื‘ืขื™ืงืจ ื‘ืขืงื‘ โ€“ ืชื•ืคืขื” ื”ืžื›ื•ื ื” ื‘ืขื’ื” ื”ืจืคื•ืื™ืช ‘ื“ืœืงืช ื‘ื’ื™ื“ ื”ืื›ื™ืœืก’ ืื• ‘ืื›ื™ืœืก ื˜ื ื“ื™ื ื™ื˜ื™ืก’.
  • ื›ืื‘ื™ ื’ื‘ ืชื—ืชื•ืŸ: ื›ืื‘ื™ ื’ื‘ ืชื—ืชื•ืŸ ืขืฉื•ื™ื™ื ืืฃ ื”ื ืœื”ืชืคืชื— ืืฆืœ ื—ืœืง ืžื”ืžืื•ื‘ื—ื ื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืœ ืจืงืข ื“ืœืงืชื™ื•ืช ื‘ื—ื•ืœื™ื•ืช ืขืžื•ื“ ื”ืฉื“ืจื” โ€“ ืžืฆื‘ ื”ืงืจื•ื™ ื‘ืฉืคื” ื”ืจืคื•ืื™ืช ‘ืกืคื•ื ื“ื™ืœื™ื˜ื™ืก’, ืœืจื‘ื•ืช ื“ืœืงืชื™ื•ืช ื‘ื—ื•ืœื™ื•ืช ืขืฆืžืŸ ื•/ืื• ื‘ืžืคืจืงื™ื ื”ืžื—ื‘ืจื™ื ื‘ื™ืŸ ืขืžื•ื“ ื”ืฉื“ืจื” ื•ื”ืื’ืŸ โ€“ื“ืœืงืช ื‘ืžืคืจืง ื”ืื’ืŸ (ืกืงืจื•ืื™ืœื™ื˜ื™ืก).

ืชืกืžื™ื ื™ื ืขื•ืจื™ื™ื

ืœืฆื“ ืืœื”, ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืžืชื‘ื˜ืืช ื’ื ื‘ืชืกืžื™ื ื™ื ืขื•ืจื™ื™ื ืฉืžืืคื™ื™ื ื™ื ืคืกื•ืจื™ืื–ื™ืก. ืคืกื•ืจื™ืื–ื™ืก ืžื•ืคื™ืขื” ื‘ืžื’ื•ื•ืŸ ืฆื•ืจื•ืช, ื›ืฉื”ื ื’ืขื™ื ื”ืฉื›ื™ื—ื™ื ื‘ื™ื•ืชืจ ืžื•ืคื™ืขื™ื ื›’ืคืกื•ืจื™ืื–ื™ืก ืจื•ื‘ื“ื™’ย  โ€“ ืจื‘ื“ื™ื ืฉืœ ื ื’ืขื™ื ืื“ื•ืžื™ื ืžืชื•ื—ืžื™ื ืžื›ื•ืกื™ื ืงืฉืงืฉืช ื›ืกื•ืคื” ืขื‘ื” ืฉื ื•ืฉืจืช ื‘ืงืœื•ืช. ื”ื ื’ืขื™ื ืžื•ืคื™ืขื™ื ืœืจื•ื‘ ื‘ืงืจืงืคืช ื•ื‘ื—ืœืงื™ื ื”ืžื™ื™ืฉืจื™ื ืฉืœ ื”ื’ืคื™ื™ื (ืžืจืคืงื™ื ื•ื‘ืจื›ื™ื™ื) ืืš ื™ื›ื•ืœื™ื ืœื”ื•ืคื™ืข ื‘ื›ืœ ืื–ื•ืจ ื‘ื’ื•ืฃ.

ืžื”ื ื’ื•ืจืžื™ ื”ืกื™ื›ื•ืŸ?

  1. ื’ื•ืจืžื™ื ื›ืœืœื™ื™ื

ืžืกืคืจ ื’ื•ืจืžื™ื ื›ืœืœื™ื™ื ื ืงืฉืจื• ืœื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช:

  • ืžื—ืœืช ื”ืคืกื•ืจื™ืื–ื™ืก ื”ื™ื ื›ืžื•ื‘ืŸ ื’ื•ืจื ื”ืกื™ื›ื•ืŸ ื”ืžืฉืžืขื•ืชื™ ื‘ื™ื•ืชืจ ืœื”ืชืคืชื—ื•ืช ืขืชื™ื“ื™ืช ืฉืœ ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช. ื™ื•ื“ื’ืฉ ื›ื™ ื™ืฉื ื ืžืฆื‘ื™ื ื‘ื”ื ื”ื“ืœืงืชื™ื•ืช ื‘ืžืคืจืงื™ื ื”ื—ืœื” ืขื•ื“ ืœืคื ื™ ื”ื•ืคืขืช ื”ื ื’ืขื™ื ื”ืขื•ืจื™ื™ื, ืืš ื‘ืฉืœื‘ื™ื ื”ืจืืฉื•ื ื™ื ื”ื™ื ืื™ื ื” ื’ืœื•ื™ื” ืœืขื™ืŸ, ื•ืœื›ืŸ ื‘ืจื•ื‘ ื”ืžืงืจื™ื ื”ื—ื•ืœื™ื ื™ืื•ื‘ื—ื ื• ืชื—ื™ืœื” ืขื ืคืกื•ืจื™ืื–ื™ืก. ืžื‘ื™ืŸ ื—ื•ืœื™ ื”ืคืกื•ืจื™ืื–ื™ืก, ื”ืกื™ื›ื•ืŸ ืœื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื’ื‘ื•ื” ื‘ืžื™ื•ื—ื“ ืืฆืœ ื—ื•ืœื™ื ืขื ืคืกื•ืจื™ืื–ื™ืก ืžื—ืœื” ื”ืžืชื‘ื˜ืืช ื‘ื ื’ืขื™ื ื”ืžืžื•ืงื“ื™ื ืขืœ ื’ื‘ื™ ืฆื™ืคื•ืจื ื™ ื›ืคื•ืช ื”ื™ื“ื™ื™ื ืื• ื”ืจื’ืœื™ื™ื.
  • ื’ื™ืœ: ืœืžืจื•ืช ืฉื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืฉื•ื™ื” ืœื”ืชืคืชื— ื‘ื›ืœ ื’ื™ืœ, ื”ื™ื ืœืจื•ื‘ ืžื•ืคื™ืขื” ื‘ืขื™ืงืจ ื‘ืงืจื‘ ื‘ื•ื’ืจื™ื ื‘ื’ื™ืœื™ 30 ืขื“ 50.
  • ืขื•ื“ืฃ ืžืฉืงืœ ื•ื”ืฉืžื ื”: ืžื—ืงืจื™ื ืžืฆื‘ื™ืขื™ื ืขืœ ื›ืš ืฉืขื•ื“ืฃ ืžืฉืงืœ ื•ื”ืฉืžื ื” ืขืฉื•ื™ื™ื ืœื”ื•ื•ืช ื’ื•ืจื ืœื”ืชืคืจืฆื•ืช ื”ืžื—ืœื”. ื›ืš, ืžื—ืงืจ ืžืื™ืกืœื ื“ ืฉืžืชื‘ืกืก ืขืœ ืžืื’ืจ ื ืจื—ื‘ ืฉืœ 75,395 ื—ื•ืœื™ื ื‘ืคืกื•ืจื™ืื–ื™ืก ืžื‘ืจื™ื˜ื ื™ื”, ืฉืžืžืฆืื™ื• ืคื•ืจืกืžื• ื‘ืื•ื’ื•ืกื˜ 2012 ื‘ื›ืชื‘ ื”ืขืช Annals of the Rheumatic Diseases, ืžืฆื ื›ื™ ื‘ืžืขืงื‘ ื‘ื™ืŸ ื”ืฉื ื™ื 1995 ืขื“ 2010, ื”ืกื™ื›ื•ืŸ ืฉืœ ื—ื•ืœื™ ืคืกื•ืจื™ืื–ื™ืก ืœืคืชื— ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื’ื‘ื•ื” ื‘-9% ืœื—ื•ืœื™ื ื‘ืขื•ื“ืฃ ืžืฉืงืœ (ื›ืฉืžื“ื“ ื”ื”ืฉืžื ื” BMI ื”ื•ื ื‘ื™ืŸ 25 ืœ-30 ื™ื—ื™ื“ื•ืช), ื’ื‘ื•ื” ื‘-22% ืœื—ื•ืœื™ื ืขื ื”ืฉืžื ื” (ื›ืฉืžื“ื“ ื”ื”ืฉืžื ื” ื‘ื™ืŸ 30 ืœ-35 ื™ื—ื™ื“ื•ืช) ื•ื’ื‘ื•ื” ื‘-48% ืœื—ื•ืœื™ื ืขื ื”ืฉืžื ื” ื—ื•ืœื ื™ืช (ื›ืฉืžื“ื“ ื”ื”ืฉืžื ื” ื”ื•ื 35 ื™ื—ื™ื“ื•ืช ื•ืžืขืœื”), ื‘ื”ืฉื•ื•ืื” ืœื—ื•ืœื™ื ื‘ืžืฉืงืœ ืชืงื™ืŸ (ืขื“ 25 ื™ื—ื™ื“ื•ืช ื‘ืžื“ื“ ื”ื”ืฉืžื ื”).
  1. ื’ื•ืจืžื™ื ื’ื ื˜ื™ื™ื

ืžื—ืงืจื™ื ืžืขืœื™ื ื›ื™ ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื ื•ื˜ื” ืœื”ืชืคืจืฅ ืืฆืœ ืื ืฉื™ื ืขื ื”ื™ืกื˜ื•ืจื™ื” ืžืฉืคื—ืชื™ืช ืฉืœ ื”ืžื—ืœื” ืื• ืฉืœ ืคืกื•ืจื™ืื–ื™ืก. ืœืคื™ ืžื—ืงืจื™ื, ืœื›-40% ืžื”ืื ืฉื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื™ืฉ ืœืคื—ื•ืช ืงืจื•ื‘ ืžืฉืคื—ื” ืื—ื“ ืžื“ืจื’ื” ืจืืฉื•ื ื” ืฉืžืื•ื‘ื—ืŸ ืขื ื”ืžื—ืœื” ืื• ืขื ืคืกื•ืจื™ืื–ื™ืก. ื—ื•ืงืจื™ื ื–ื™ื”ื• ื‘ืฉื ื™ื ื”ืื—ืจื•ื ื•ืช ืžืกืคืจ ืฉื™ื ื•ื™ื™ื ื’ื ื˜ื™ื™ื (ืžื•ื˜ืฆื™ื•ืช) ืฉื ืงืฉืจื• ืœื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช. ื‘ืขื™ืงืจ ื–ื•ื”ื” ืงืฉืจ ื‘ื™ืŸ ื”ืžื—ืœื” ืœื‘ื™ืŸ ื”ืกืžืŸ ื”ื’ื ื˜ื™ HLA-B27, ืื•ืœื ื‘ืฉื›ื™ื—ื•ืช ื ืžื•ื›ื” ื™ื•ืชืจ ื‘ื”ืฉื•ื•ืื” ืœื—ื•ืœื™ื ื‘ื“ืœืงืช ื—ื•ืœื™ื•ืช ืžืงืฉื—ืช โ€“ ื•ื‘ืขื™ืงืจ ื‘ืงืจื‘ ื—ื•ืœื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืฉืžืขืจื‘ืช ืืช ืžืคืจืงื™ ืขืžื•ื“ ื”ืฉื“ืจื”, ื•ืžืกื™ื‘ื” ื–ื• โ€“ ื‘ื“ื™ืงื” ืœื ื•ื›ื—ื•ืช ืกืžืŸ ื–ื” ื‘ื“ื ืœื ืžื‘ื•ืฆืขืช ื‘ื“ืจืš ืงื‘ืข ืœืžืื•ื‘ื—ื ื™ื ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช. ื›ืžื• ื›ืŸ, ืœื›-10% ืžื”ื—ื•ืœื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื ื™ืชืŸ ืœื–ื”ื•ืช ืกืžื ื™ื ื’ื ื˜ื™ื™ื (ืžื•ื˜ืฆื™ื•ืช) ืฉื ืงืฉืจื• ื‘ืžื—ืงืจื™ื ืœื”ืชืคืชื—ื•ืช ืคืกื•ืจื™ืื–ื™ืก.

  1. ื’ื•ืจืžื™ื ืกื‘ื™ื‘ืชื™ื™ื

ื’ื•ืจืžื™ื ืกื‘ื™ื‘ืชื™ื™ื ื ืงืฉืจื• ืืฃ ื”ื ื‘ืžื—ืงืจื™ื ืœื”ืชืคืจืฆื•ืช ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื•ื‘ื›ืœืœื: ื˜ืจืื•ืžื”: ืžืกืคืจ ืคืจืกื•ืžื™ื ื‘ืกืคืจื•ืช ื”ืจืคื•ืื™ืช ืžื–ื”ื™ื ืงืฉืจ ืืคืฉืจื™ ื‘ื™ืŸ ืคื’ื™ืขื” ื˜ืจืื•ืžื˜ื™ืช ืœื”ืชืคืชื—ื•ืช ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช. ื›ืš, ืœืžืฉืœ, ื‘ืชื™ืื•ืจ ืžืงืจื” ืฉืคื•ืจืกื ื‘ื ื•ื‘ืžื‘ืจ 2012 ื‘ื›ืชื‘ ื”ืขืช Canadian Family Physician ืžื“ื•ื•ื— ืขืœ ืฆื‘ืขื™ ื‘ืŸ 39 ืฉืคื™ืชื— ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื‘ืขื™ืงืจ ื‘ืคืจืงื™ ื›ืคื•ืช ื”ื™ื“ื™ื™ื ื‘ืกืžื™ื›ื•ืช ืœื—ื‘ืœื” ื‘ื™ื“ื• ืขืœ ืจืงืข ืคืฆื™ืขื” ื‘ืขื‘ื•ื“ื”. ืงื‘ื•ืฆืช ื—ื•ืงืจื™ื ืžืื™ื˜ืœื™ื” ื–ื™ื”ื• ืขื•ื“ ื‘ืฉื ื•ืช ื”-90 ื›ื™ ื‘ืžื“ื’ื ืฉืœ 300 ื—ื•ืœื™ื ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขื‘ืจื• 8% ืžื”ืžื˜ื•ืคืœื™ื ื˜ืจืื•ืžื” ื‘ืฉืœื•ืฉืช ื”ื—ื•ื“ืฉื™ื ืฉืงื“ืžื• ืœืื‘ื—ื ืช ื”ืžื—ืœื” โ€“ ืฉื›ื™ื—ื•ืช ื’ื‘ื•ื”ื” ื‘ื”ืฉื•ื•ืื” ืœื“ืœืงื•ืช ืžืคืจืงื™ื ืื—ืจื•ืช, ื•ื‘ืžืืžืจ ืฉืคื•ืจืกื ื‘ืื‘ื™ื‘ 1998 ื‘ื›ืชื‘ ื”ืขืช Clinical and Experimental Rheumatology ืžื“ื•ื•ื—ื™ื ื”ื—ื•ืงืจื™ื ื›ื™ ืงื™ื™ืžื™ื ืžืกืคืจ ืžืืคื™ื™ื ื™ื ืงืœื™ื ื™ื™ื ื™ื™ื—ื•ื“ื™ื™ื ืฉืžื‘ื—ื™ื ื™ื ื—ื•ืœื™ื ืฉืคื™ืชื—ื• ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืœ ืจืงืข ื˜ืจืื•ืžื” ื‘ื”ืฉื•ื•ืื” ืœื—ื•ืœื™ื ืื—ืจื™ื. ื‘ืžื—ืงืจ ื–ื” ืืฃ ืžื›ื•ื ื” ื”ืชื•ืคืขื” ื‘ืฉื ืฉืœ “ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืคื•ืกื˜ ื˜ืจืื•ืžื˜ื™ืช”.

  • ื–ื™ื”ื•ื: ื–ื™ื”ื•ื ื—ื™ื™ื“ืงื™ ืื• ื ื’ื™ืคื™ ืขืฉื•ื™ ืœืขื•ื“ื“ ื”ืชืคืจืฆื•ืช ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืืฆืœ ืื ืฉื™ื ืขื ื ื˜ื™ื™ื” ืžื•ืœื“ืช ืœืžื—ืœื”. ืกืงื™ืจื” ืฉืœ ื—ื•ืงืจื™ื ืžืื™ืกืœื ื“ ืฉืคื•ืจืกืžื” ื‘ื ื•ื‘ืžื‘ืจ 2018 ื‘ื›ืชื‘ ื”ืขืช Rheumatology International ืžื•ื ื” ืžืกืคืจ ืขื‘ื•ื“ื•ืช ืฉื–ื™ื”ื• ืงืฉืจ ื‘ื™ืŸ ื–ื™ื”ื•ืžื™ื ืฉื•ื ื™ื ืœื‘ื™ืŸ ื”ืชืคืชื—ื•ืช ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช, ืœืจื‘ื•ืช ื–ื™ื”ื•ื ื‘ื—ื™ื™ื“ืง ื”ืกื˜ืจืคื˜ื•ืงื•ืง ื•ื—ื™ื™ื“ืง ื”ื›ืœืžื™ื“ื™ื” ื•ื‘ื ื’ื™ืฃ ื”-HIV, ืื•ืœื ื›ื›ืœืœ โ€“ ืœื ื ืžืฆื ื‘ื ื™ืชื•ื— ืงืฉืจ ื›ื•ืœืœ ื‘ื™ืŸ ื–ื™ื”ื•ืžื™ื ืœื”ืชืคืชื—ื•ืช ื”ืžื—ืœื”.
  • ืขื™ืฉื•ืŸ: ืขื‘ื•ื“ื•ืช ืฉื•ื ื•ืช ืžืฆื‘ื™ืขื•ืช ืขืœ ืงืฉืจ ืžื•ืจื›ื‘ ื‘ื™ืŸ ืขื™ืฉื•ืŸ ืกื™ื’ืจื™ื•ืช ืœื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช. ืžื—ืงืจ ืืžืจื™ืงืื™ ืฉืžืžืฆืื™ื• ืคื•ืจืกืžื• ื‘ื™ื ื•ืืจ 2018 ื‘ื›ืชื‘ ื”ืขืช Annals of Rheumatic Diseases, ืžืฆื ื›ื™ ืขื™ืฉื•ืŸ ืžืขืœื” ืืช ื”ืกื™ื›ื•ืŸ ืœื”ืชืคืชื—ื•ืช ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื‘ืื•ื›ืœื•ืกื™ื™ื” ื”ื›ืœืœื™ืช ืืš ืงืฉื•ืจ ืœืกื™ื›ื•ืŸ ืžื•ืคื—ืช ืœื”ืชืคืชื—ื•ืช ื”ืžื—ืœื” ื‘ืงืจื‘ ืื ืฉื™ื ืขื ืคืกื•ืจื™ืื–ื™ืก. ื’ื ื‘ื”ืงืฉืจ ืœืกื™ื›ื•ืŸ ืœื”ืชืœืงื—ื•ื™ื•ืช โ€“ ื™ืฉ ืขื‘ื•ื“ื•ืช ืฉืžืฆื‘ื™ืขื•ืช ืขืœ ืงืฉืจ ื‘ื™ืŸ ืขื™ืฉื•ืŸ ืœื”ื—ืžืจื” ื‘ืžื—ืœื”, ื•ืื™ืœื• ื™ืฉื ื ืžื—ืงืจื™ื ืฉืื™ื ื ืžื–ื”ื™ื ืงืฉืจ ืžืกื•ื’ ื–ื”.
  • ืชื–ื•ื ื”: ืžืกืคืจ ืžื—ืงืจื™ื ืžื–ื”ื™ื ืžืจื›ื™ื‘ื™ื ืชื–ื•ื ืชื™ื™ื ืฉืขืฉื•ื™ื™ื ืœืขื•ื“ื“ ื”ืชืœืงื—ื•ื™ื•ืช ืฉืœ ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช, ืœืจื‘ื•ืช ืฆืจื™ื›ื” ืžื•ื’ื‘ืจืช ืฉืœ ืกื•ื›ืจ, ื‘ืฉืจ ืื“ื•ื ื•ื™ืฉ ืืฃ ืขื‘ื•ื“ื•ืช ืฉืžื“ื’ื™ืžื•ืช ืงืฉืจ ื‘ื™ืŸ ืฆืจื™ื›ื” ืขื•ื“ืคืช ืฉืœ ืžื•ืฆืจื™ ื—ืœื‘ ืœื‘ื™ืŸ ื“ืœืงืชื™ื•ืช ืžื•ื’ื‘ืจืช ื•ื”ืชืœืงื—ื•ืช ื”ืžื—ืœื”.

ย 

ื”ื˜ื™ืคื•ืœื™ื ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช

ื›ื™ื•ื ืื™ืŸ ื‘ื ืžืฆื ื˜ื™ืคื•ืœ ืฉืžืจืคื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช, ืืš ื™ืฉื ื ื˜ื™ืคื•ืœื™ื ืฉืžืืคืฉืจื™ื ืœืฉืœื•ื˜ ืขืœ ืขื•ืฆืžืช ื”ื“ืœืงืชื™ื•ืช ื‘ืžืคืจืงื™ื, ืœื”ืคื—ื™ืช ืืช ื”ืชืกืžื™ื ื™ื ื”ืื•ืคื™ื™ื ื™ื™ื ื‘ืžืคืจืงื™ื ื•ื‘ืขื•ืจ ื•ืœืžื ื•ืข ื”ื™ื“ืจื“ืจื•ืช ืฉืœ ื”ืžื—ืœื” ืœื›ื“ื™ ื ื›ื•ืช ืชืคืงื•ื“ื™ืช.

ื‘ื—ื™ืจืช ื”ื˜ื™ืคื•ืœ ื”ืชืจื•ืคืชื™ ืœื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช, ืœืจื‘ื•ืช ืชืจื•ืคื•ืช ื‘ื™ื•ืœื•ื’ื™ื•ืช/ ืชืจื•ืคื•ืช ื”ืžื•ืจื›ื‘ื•ืช ืžืžื•ืœืงื•ืœื•ืช ืงื˜ื ื•ืช, ื ื’ื–ืจ ืžืฆื•ืจืช ื”ืžื—ืœื”: ื™ืฉื ืŸ ืชืจื•ืคื•ืช ื™ืขื™ืœื•ืช ื™ื•ืชืจ ืœืžื—ืœื” ืขื•ืจื™ืช ื•ืชืจื•ืคื•ืช ื™ืขื™ืœื•ืช ื™ื•ืชืจ ืœืžืคืจืงื™ื. ืœืขืชื™ื ื™ืฉ ืžืงื•ื ืœืฉืœื‘ ื”ืชืืžื” ืฉืœ ื”ื˜ื™ืคื•ืœ ื”ืชืจื•ืคืชื™ ืขืœ ื™ื“ื™ ืจื•ืคื ืจืื•ืžื˜ื•ืœื•ื’ ื•ืจื•ืคื ื”ืขื•ืจ, ื•ื‘ื—ืœืง ืžื”ืžืจื›ื–ื™ื ื”ืจืคื•ืื™ื™ื ื‘ื™ืฉืจืืœ ืžื‘ื•ืฆืขื•ืช ื”ืขืจื›ื•ืช ืžืฉื•ืชืคื•ืช ืฉืœ ืจื•ืคืื™ื ืžืฉื ื™ ืชื—ื•ืžื™ ืžื•ืžื—ื™ื•ืช ืืœื” ืœืžืื•ื‘ื—ื ื™ื ื‘ืžื—ืœื”.

ื”ืชืจื•ืคื•ืช ื”ืžืฉืžืฉื•ืช ืœื˜ื™ืคื•ืœ ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื›ื•ืœืœื•ืช:

  • ืžืฉื›ื›ื™ ื›ืื‘ื™ื ืžืงื‘ื•ืฆืช NSAIDs – ื”ื˜ื™ืคื•ืœ ื”ืจืืฉื•ื ื™ ืœื—ื•ืœื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช, ื‘ืžื™ื•ื—ื“ ื‘ืฆื•ืจื” ืื•ืœื™ื’ื•ืืจื˜ื™ืงื•ืœืจื™ืช ืฉืžืชื‘ื˜ืืช ื‘ื—ืžื™ืฉื” ืžืคืจืงื™ื ืœื›ืœ ื”ื™ื•ืชืจ ื ื™ืชืŸ ืœืจื•ื‘ ื‘ืชืจื•ืคื•ืช ืžืจืฉื ืœืฉื™ื›ื•ืš ื›ืื‘ื™ื ืžืงื‘ื•ืฆืช NSAIDs. ื˜ื™ืคื•ืœ ื–ื” ืื™ื ื• ืžืชืื™ื ืœืจื•ื‘ ืœื“ืœืงืช ืžืคืจืงื™ื ืคื•ืœื™ืืจื˜ื™ืงื•ืœืจื™ืช โ€“ ื‘ืžืกืคืจ ืจื‘ ืฉืœ ืžืคืจืงื™ื. ื”ืชืจื•ืคื•ืช ื“ื•ืจืฉื•ืช ืžืจืฉื ืจื•ืคื, ื›ื’ื•ืŸ ืืจืงื•ืงืกื™ื”, ืืชื•ืคืŸ, ืกืœืงื•ืงืก ื•ืื—ืจื•ืช. ื—ืœืง ืžื”ืชืจื•ืคื•ืช ื›ืœื•ืœื•ืช ื‘ืกืœ ื•ื—ืœืงืŸ ื ื™ืชื ื•ืช ืœืจื›ื™ืฉื” ื‘ื”ื ื—ื•ืช ื“ืจืš ื”ื‘ื™ื˜ื•ื—ื™ื ื”ืžืฉืœื™ืžื™ื ืฉืœ ืงื•ืคื•ืช ื”ื—ื•ืœื™ื. ื›ื›ืœืœ, ื‘ื™ื›ื•ืœืชืŸ ืฉืœ ืชืจื•ืคื•ืช ืืœื” ืœืžืชืŸ ืืช ื”ืคืขื™ืœื•ืช ื”ื“ืœืงืชื™ืช ื•ืœื”ืคื—ื™ืช ื‘ื›ืื‘ื™ื ื•ื‘ืชืกืžื™ื ื™ ื ื•ืงืฉื•ืช ื‘ื•ืงืจ, ืขื ื”ืชื—ืœืช ืคืขื•ืœื” ืžื”ื™ืจื”. ืชื•ืคืขื•ืช ื”ืœื•ื•ืื™ ืฉืœ ืฉื™ืžื•ืฉ ืžืžื•ืฉืš ื‘ืชืจื•ืคื•ืช ืืœื” ืขืฉื•ื™ื•ืช ืœื›ืœื•ืœ ื›ืื‘ื™ื/ ืื™ ื ื•ื—ื•ืช ื‘ื‘ื˜ืŸ, ื‘ืขื™ื•ืช ืœื‘ื‘ื™ื•ืช ื•ืกื™ื‘ื•ื›ื™ื ื‘ื›ื‘ื“ ื•ื‘ื›ืœื™ื•ืช. ื‘ืžืงืจื™ื ืฉืœ ื›ื™ื‘ ืงื™ื‘ื”, ืื™ ืกืคื™ืงืช ืœื‘, ื”ืคืจืขื” ื‘ืชืคืงื•ื“ ื›ืœื™ื•ืช ืื• ื›ื‘ื“ ืื• ืžื—ืœืช ืžืขื™ ื“ืœืงืชื™ืช, ืœื ื ื™ืชืŸ ืœื˜ืคืœ ื‘ืชืจื•ืคื•ืช ืืœื”, ื•ื™ืฉ ืฆื•ืจืš ื‘ื˜ื™ืคื•ืœ ื—ื™ืœื•ืคื™.
  • ืกื˜ืจื•ืื™ื“ื™ื – ืœื—ื•ืœื™ื ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื ื™ืชื ื™ื ืœืขืชื™ื ืกื˜ืจื•ืื™ื“ื™ื ืžืžืฉืคื—ืช ื”ื’ืœื•ืงื•ืงื•ืจื˜ื™ืงื•ื™ื“ื™ื ื‘ืขืœื™ ืคืขื™ืœื•ืช ืื ื˜ื™ ื“ืœืงืชื™ืช ื›ืœืœื™ืช, ืฉื‘ืืคืฉืจื•ืชื ืœื”ืงืœ ืขืœ ืชืกืžื™ื ื™ ื“ืœืงื•ืช ืžืคืจืงื™ื. ื”ื˜ื™ืคื•ืœ ื ื™ืชืŸ ื‘ืขื™ืงืจ ื‘ืฆื•ืจื” ืฉืœ ื”ื–ืจืงืช ืกื˜ืจื•ืื™ื“ื™ื ื‘ืขืœื™ ื”ืฉืคืขื” ืืจื•ื›ื”, ื›ื’ื•ืŸ ืžืชื™ืœืคืจื“ื ื™ื–ื•ืœื•ืŸ (ื“ืคื•ืžื“ืจื•ืœ, ื”ืงืกื˜ืจื™ืื•ืŸ ื•ืกืœืกื˜ื•ืŸ), ืœืชื•ืš ื”ืžืคืจืง, ืกืžื•ืš ืœืžืคืจืง ืื• ืœืžืขื˜ืคืช ืฉืœ ื”ื’ื™ื“, ืœื”ืงืœื” ืฉืœ ื›ืื‘ ื•ืฉืœ ื“ืœืงืช. ื”ืฉื™ืžื•ืฉ ื‘ื’ืœื•ืงื•ืงื•ืจื˜ื™ืงื•ื™ื“ื™ื ืกื™ืกื˜ืžื™ื™ื ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ื”ื™ื ื• ืžืฆื•ืžืฆื ืœืื•ืจ ื”ืขื•ื‘ื“ื” ืฉื˜ื™ืคื•ืœ ื–ื” ืขืœื•ืœ ืœื”ื—ืžื™ืจ ืืช ื”ืžืฆื‘ ืฉืœ ื”ืคืกื•ืจื™ืื–ื™ืก.
  • ืชืจื•ืคื•ืช ืžืงื‘ื•ืฆืช DMARDs ื”ื˜ื™ืคื•ืœ ื”ืชืจื•ืคืชื™ ื”ืขื™ืงืจื™ ื‘ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืœืื—ืจ ืฉืื•ื‘ื—ื ื” ื ื™ืชืŸ ื‘ืชืจื•ืคื•ืช ืžืงื‘ื•ืฆื” ื”ืงืจื•ื™ื” ื‘ืฉื ื”ื›ื•ืœืœ conventional synthetic DMARDs (ืงื™ืฆื•ืจ ืฉืœ conventional synthetic Disease Modifying Anti-Rheumatic Drugs). ืงื‘ื•ืฆื” ื–ื• ืžื›ื™ืœื” ืชืจื•ืคื•ืช ืžืงื‘ื•ืฆื•ืช ืฉื•ื ื•ืช โ€“ ืžื˜ื•ื˜ืจืงืกื˜, ืขืจื‘ื” ื•ืกืœืื–ื•ืคื™ืจื™ืŸ โ€“ ื”ืคื•ืขืœื•ืช ืœื“ื™ื›ื•ื™ ืฉืœ ื”ืžืขืจื›ืช ื”ื—ื™ืกื•ื ื™ืช, ืืฉืจ ืžืฉืคื™ืขื•ืช ืขืœ ืžื”ืœืš ื”ืžื—ืœื” ื”ื“ืœืงืชื™ืช ืื• ื‘ืขืœื•ืช ื™ื›ื•ืœืช ืœืขืฆื•ืจ ืืช ื”ืชืงื“ืžื•ืช ื”ืžื—ืœื”. ื”ืฉืคืขืชืŸ ืฉืœ ืชืจื•ืคื•ืช ืžืงื‘ื•ืฆื” ื–ื• ืขืœ ื“ืœืงืช ื”ืžืคืจืงื™ื ื ืฆืคื™ืช ืชื•ืš ื—ื•ื“ืฉ ืขื“ ืฉืœื•ืฉื” ื—ื•ื“ืฉื™ื ืžืชื—ื™ืœืช ื”ื˜ื™ืคื•ืœ. ื”ื˜ื™ืคื•ืœ ืขืฉื•ื™ ืœื”ื™ื ืชืŸ ื‘ืชืจื•ืคื” ืื—ืช ื‘ืงื‘ื•ืฆืช ื”-DMARDs, ื•ื‘ืžืงืจื™ื ืจื‘ื™ื ื‘ืฉื™ืœื•ื‘ ืฉืœ ืฉืชื™ ืชืจื•ืคื•ืช ืžื”ืงื‘ื•ืฆื”. ืžื˜ื•ื˜ืจืงืกื˜ ื ื—ืฉื‘ืช ื›ืชืจื•ืคืช ื”ืขื•ื’ืŸ ื•ื‘ืžืงืจื” ืฉืœ ืื™-ืกื‘ื™ืœื•ืช ื ื™ืชืŸ ืœื”ื—ืœื™ืคื” ื‘ื˜ื™ืคื•ืœ ื‘ืขืจื‘ื”. ืชื•ืคืขื•ืช ื”ืœื•ื•ืื™ ื”ืืคืฉืจื™ื•ืช ืžืฉืชื ื•ืช, ื•ืกื™ื‘ื•ื›ื™ ื”ืชืจื•ืคื•ืช ื‘ืงื‘ื•ืฆื” ื–ื• ืขืฉื•ื™ื™ื ืœื›ืœื•ืœ ืคื’ื™ืขื” ื‘ื›ื‘ื“ ื•ื“ื™ื›ื•ื™ ืฉืœ ืžื•ื— ื”ืขืฆื.

ื”ื—ื™ื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช

ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืฉื•ื™ื” ืœื”ืฉืคื™ืข ื‘ืื•ืคืŸ ืžืฉืžืขื•ืชื™ ืขืœ ืื™ื›ื•ืช ื”ื—ื™ื™ื ื•ื“ื•ืจืฉืช ื”ืชืืžื•ืช ืžืกื•ื™ืžื•ืช.

  • ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืฉื•ื™ื” ืœื”ืฉืคื™ืข ื‘ืื•ืคืŸ ืžืฉืžืขื•ืชื™ ืขืœ ืื™ื›ื•ืช ื”ื—ื™ื™ื ื•ื“ื•ืจืฉืช ื”ืชืืžื•ืช ืžืกื•ื™ืžื•ืช.
    • ื‘ื“ื™ืงื•ืช ืชืงื•ืคืชื™ื•ืช – ืœืžืื•ื‘ื—ื ื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืžื•ืžืœืฅ ืœื”ืงืคื™ื“ ืขืœ ื‘ื“ื™ืงื•ืช ืชืงื•ืคืชื™ื•ืช ืืฆืœ ื”ืจืื•ืžื˜ื•ืœื•ื’ ื”ืžื˜ืคืœ, ืœืจื•ื‘ ื›ืœ 6-3 ื—ื•ื“ืฉื™ื โ€“ ื›ื“ื™ ืœื‘ื—ื•ืŸ ืืช ื”ืชืงื“ืžื•ืช ื”ืžื—ืœื” ื‘ืืžืฆืขื•ืช ื‘ื“ื™ืงื•ืช ื”ื“ื ื•ื‘ื“ื™ืงื•ืช ื”ื”ื“ืžื™ื” ื•ืœื‘ื—ื•ืŸ ืืช ืชืžื”ื™ืœ ื”ื˜ื™ืคื•ืœ ื”ืชืจื•ืคืชื™ ื•ื™ืขื™ืœื•ืชื•.
    • ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช – ืœืกื•ื‘ืœื™ื ืžื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืžื•ืžืœืฅ ืœื”ืชืื™ื ืืช ื”ืคืขื™ืœื•ืช ื”ื™ื•ืžื™ื•ืžื™ืช ื•ืžื™ื“ืช ื”ืžืืžืฅ โ€“ ื‘ื”ืชืื ืœืžืฆื‘ ื”ืžื—ืœื”. ืขื ื–ืืช, ืœืžืื•ื‘ื—ื ื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืžื•ืžืœืฅ ื—ืจืฃ ืชืกืžื™ื ื™ ื”ืžื—ืœื” ืœื”ืงืคื™ื“ ืขืœ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืงื‘ื•ืขื” ืฉืขืฉื•ื™ื” ืœืฉืคืจ ืืช ื’ืžื™ืฉื•ืช ื”ืžืคืจืงื™ื ื•ืœื—ื–ืง ืืช ืฉืจื™ืจื™ ื”ื’ื•ืฃ. ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืกื“ื™ืจื” ื’ื ืžืกื™ื™ืขืช ืœืžื ื•ืข ืกื™ื‘ื•ื›ื™ื ืฉืœ ื”ืžื—ืœื”, ื›ื’ื•ืŸ ืžื—ืœื•ืช ืœื‘ ื•ื›ืœื™ ื“ื, ืกื•ื›ืจืช ื•ืžื—ืœื•ืช ืžืขื™ ื“ืœืงืชื™ื•ืช. ืžื•ืžืœืฅ ืœื”ืงืคื™ื“ ืขืœ ืคืขื™ืœื•ืช ื”ื’ื•ืคื ื™ืช ื‘ื”ืชืื ืœื”ืžืœืฆื•ืช ืืจื’ื•ืŸ ื”ื‘ืจื™ืื•ืช ื”ืขื•ืœืžื™ (WHO) ืœื›ืœืœ ื”ืื•ื›ืœื•ืกื™ื™ื” ื”ื‘ื•ื’ืจืช โ€“ 150 ื“ืงื•ืช ืœืคื—ื•ืช ืœืฉื‘ื•ืข ืฉืœ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื‘ื“ืจื’ืช ืขืฆื™ืžื•ืช ืžืชื•ื ื”-ื‘ื™ื ื•ื ื™ืช ื”ืคื–ื•ืจื™ื ื‘ืจื•ื‘ ื™ืžื™ ื”ืฉื‘ื•ืข, ื›ืฉื”ืคืขื™ืœื•ืช ื”ืžื•ืžืœืฆืช ื‘ื™ื•ืชืจ ื”ื™ื ื–ื• ืฉืžืคืขื™ืœื” ืคื—ื•ืช ืœื—ืฅ ืขืœ ื”ืžืคืจืงื™ื, ื›ื’ื•ืŸ ืจื›ื™ื‘ื” ืขืœ ืื•ืคื ื™ื™ื, ืฉื—ื™ื™ื” ื•ื”ืœื™ื›ื” ืžื”ื™ืจื”.
    • ืฉืžื™ืจื” ืขืœ ืžืฉืงืœ ืชืงื™ืŸ – ืฉืžื™ืจื” ืขืœ ืžืฉืงืœ ื’ื•ืฃ ืชืงื™ืŸ ืžืกื™ื™ืขืช ืœืžื ื•ืข ื”ืคืขืœืช ืœื—ืฅ ืขืœ ื”ืžืคืจืงื™ื ื•ื‘ื›ืš ืชื•ืจืžืช ืœื”ืคื—ืชื” ื‘ื›ืื‘ ื•ืœื”ื’ื‘ืจืช ื™ื›ื•ืœืช ื”ืชื ื•ืขืชื™ื•ืช. ืœืคื™ ืžื—ืงืจื™ื, ื”ื•ืจื“ืช ืžืฉืงืœ ืขื•ื“ืฃ ืืฃ ืขืฉื•ื™ื” ืœืฉืคืจ ืืช ื”ืชื’ื•ื‘ื” ืœื˜ื™ืคื•ืœื™ื ื”ืชืจื•ืคืชื™ื™ื, ืžืื—ืจ ื•ื—ืœืง ืžื”ืชืจื•ืคื•ืช ืžืฉืคื™ืขื•ืช ื‘ืจืžื” ื ืžื•ื›ื” ื™ื•ืชืจ ืขืœ ื—ื•ืœื™ื ืขื ืขื•ื“ืฃ ืžืฉืงืœ ื•ื”ืฉืžื ื”. ื›ืš, ืœืžืฉืœ, ื‘ืžื—ืงืจ ืฉืคื•ืจืกื ื‘ืืคืจื™ืœ 2017 ื‘ื›ืชื‘ ื”ืขืช JAMA Surgery ื ืžืฆื ื›ื™ ืืฆืœ ืื ืฉื™ื ืขื ื”ืฉืžื ื” ื—ื•ืœื ื™ืช ื•ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช โ€“ ื ื™ืชื•ื— ื‘ืจื™ืื˜ืจื™ ืœืงื™ืฆื•ืจ ืงื™ื‘ื” ื‘ืฉื™ื˜ืช ‘ืžืขืงืฃ ืงื™ื‘ื”’ ื”ื•ื ืืžืฆืขื™ ื™ืขื™ืœ ืœื”ืคื—ืชืช ืชืกืžื™ื ื™ ื”ืžื—ืœื” ื•ื—ื•ืžืจืชื”. ื™ืฉื ืŸ ื’ื ืขื‘ื•ื“ื•ืช ืฉืžืฆื‘ื™ืขื•ืช ืขืœ ืงืฉืจ ื‘ื™ืŸ ื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื”ื’ื•ืฃ ืœื ืกื™ื’ื” ืฉืœ ืชืกืžื™ื ื™ ืคืกื•ืจื™ืื–ื™ืก.
    • ื’ืžื™ืœื” ืžืขื™ืฉื•ืŸ – ื”ืคืกืงืช ืขื™ืฉื•ืŸ ืกื™ื’ืจื™ื•ืช ืžื™ื˜ื™ื‘ื” ื›ืžื•ื‘ืŸ ืขื ื”ื‘ืจื™ืื•ืช ื”ื›ืœืœื™ืช ื•ื™ืขื™ืœื” ืœืฉื•ืจื” ืืจื•ื›ื” ืฉืœ ืžืฆื‘ื™ื ืจืคื•ืื™ื™ื. ื‘ืื•ืคืŸ ืกืคืฆื™ืคื™, ืืฆืœ ืื ืฉื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขื™ืฉื•ืŸ ืกื™ื’ืจื™ื•ืช ืงืฉื•ืจ ืขื ืกื™ื›ื•ืŸ ืžื•ื’ื‘ืจ ืœื”ื—ืจืคืช ื”ื ื’ืขื™ื ื”ืคืกื•ืจื™ืื˜ื™ื™ื ื‘ืขื•ืจ.
    • ื”ื’ื‘ืœืช ืฆืจื™ื›ืช ืืœื›ื•ื”ื•ืœ – ืžืื—ืจ ื•ืฉืชื™ื™ืช ืืœื›ื•ื”ื•ืœ ื‘ื›ืžื•ืช ืžื•ืคืจื–ืช ืžืฉืคื™ืขื” ืœืจืขื” ืขืœ ื”ืคืกื•ืจื™ืื–ื™ืก ื•ืืฃ ืขืฉื•ื™ื” ืœืคื’ื•ืข ื‘ื™ืขื™ืœื•ืช ื”ื˜ื™ืคื•ืœ ื”ืชืจื•ืคืชื™ ื•ืœื”ื’ื‘ื™ืจ ืืช ืชื•ืคืขื•ืช ื”ืœื•ื•ืื™ ืœื—ืœืง ืžื”ืชืจื•ืคื•ืช โ€“ ื›ื’ื•ืŸ ืžื˜ื•ื˜ืจืงืกื˜, ืžื•ืžืœืฅ ืœื”ื’ื‘ื™ืœ ืืช ืฉืชื™ื™ืช ื”ืืœื›ื•ื”ื•ืœ ื‘ื”ืชืื ืœื”ืžืœืฆื•ืช ื”ื›ืœืœื™ื•ืช ื”ื ื”ื•ื’ื•ืช ืœืื•ื›ืœื•ืกื™ื™ื” ื”ื‘ื•ื’ืจืช.
    • ืžื ื•ื—ื” – ื”ืชืžื•ื“ื“ื•ืช ืขื ืชืกืžื™ื ื™ ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืฉื•ื™ื” ืœื”ืงืฉื•ืช ืขืœ ื—ื™ื™ ื”ื™ื•ืžื™ื•ื, ื•ื‘ื ื•ืกืฃ ื—ืœืง ืžื”ืชืจื•ืคื•ืช ืขืฉื•ื™ื•ืช ืœื”ื•ื‘ื™ืœ ืœืขื™ื™ืคื•ืช ืžื•ื’ื‘ืจืช. ื”ืžืคืชื— ืœื—ื™ื™ื ืžื•ืฆืœื—ื™ื ื™ื•ืชืจ ืื™ื ื• ืœื”ืคืกื™ืง ืืช ื”ืคืขื™ืœื•ืช ืœื—ืœื•ื˜ื™ืŸ, ืืœื ืœืฉืœื•ื˜ ื˜ื•ื‘ ื™ื•ืชืจ ืขืœ ื”ืชืคืงื•ื“ ื”ื™ื•ืžื™ื•ืžื™ ื•ืœืงื—ืช ืคืกืงื™ ื–ืžืŸ ืœืžื ื•ื—ื” ืœืคื ื™ ื”ื’ืขื” ืœืžืฆื‘ ืฉืœ ืชืฉื™ืฉื•ืช ืžื•ื—ืœื˜ืช. ืœืื ืฉื™ื ืขื ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืžื•ืžืœืฅ ืœื—ืœืง ืคืขื™ืœื•ื™ื•ืช ื•ืžืฉื™ืžื•ืช ื‘ืขื‘ื•ื“ื” ื•ื‘ื‘ื™ืช ืœืžืงื˜ืขื™ื ืงืฆืจื™ื ื•ืœื”ืงืคื™ื“ ืขืœ ื”ืงืฆืืช ื–ืžื ื™ื ืฉื•ื ื™ื ื‘ืžืฉืš ื”ื™ื•ื ืœืฆื•ืจืš ืžื ื•ื—ื” ื•ืื’ื™ืจืช ืื ืจื’ื™ื”.
    • ื”ืชืžื•ื“ื“ื•ืช ื ืคืฉื™ืช – ื“ืœืงืช ืžืคืจืงื™ื ืคืกื•ืจื™ืื˜ื™ืช ืขืœ ืชืกืžื™ื ื™ื” ื”ืฉื•ื ื™ื ืขืฉื•ื™ื” ืœื”ื™ื•ืช ืžืืชื’ืจืช ื•ื ืงืฉืจื” ื‘ืžื—ืงืจื™ื ื‘ืกื™ื›ื•ืŸ ืžื•ื’ื‘ืจ ืœื“ื™ื›ืื•ืŸ ื•ื—ืจื“ื”. ื‘ื—ืœืง ืžื”ืžืงืจื™ื, ื”ืžืฆื•ืงื” ื”ื ืคืฉื™ืช ืขืœื•ืœื” ืœื”ื•ื‘ื™ืœ ืœื”ื—ืจืคืช ืชืกืžื™ื ื™ื, ื”ืคืกืงืช ืคืขื™ืœื•ืช ื•ืืฃ ืœื ื›ื•ืช ืชืคืงื•ื“ื™ืช. ืขืœ ื›ืŸ ืœืžืื•ื‘ื—ื ื™ื ื‘ืžื—ืœื” ืžื•ืžืœืฅ ืœืฉืงื•ืœ ืืžืฆืขื™ื ืœืฉื™ืคื•ืจ ื”ืžืฆื‘ ื”ื ืคืฉื™ ื•ื”ืคื—ืชืช ืžืชื—ื™ื ื•ืœื—ืฆื™ื ื‘ืืžืฆืขื•ืช ืžืฉืคื—ื” ื•ื—ื‘ืจื™ื ื•ืขืœ ื™ื“ื™ ืชืžื™ื›ื” ื ืคืฉื™ืช ืคืจื˜ื ื™ืช ื•ืงื‘ื•ืฆื•ืช ืชืžื™ื›ื”, ืœืคื™ ื”ืฆื•ืจืš.
ืกื’ื™ืจืช ืชืคืจื™ื˜
0
ืกืœ ื”ืงื ื™ื•ืช
ร—

ืขื’ืœืช ืงื ื™ื•ืช

ื“ื™ืœื•ื’ ืœืชื•ื›ืŸ